Sulfadiazine Sodium from Japan

Sulfadiazine sodium is the water-soluble salt form of sulfadiazine, a sulfonamide antibiotic used to treat toxoplasmosis, rheumatic fever, and as part of combination therapy for certain infections. Classified under HTS 2935.90.60.00 as a sulfonamide drug per Chapter 29 note (C)(1) for inorganic salts of organic compounds. The sodium salt retains the sulfonamide classification of the parent compound.

Duty Rate — Japan → United States

15%

Rate breakdown

9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter

9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter

Calculate with your customs value Verify with the Tariff Assistant

Import Tips

• Include pharmacopeial certificates (USP/EP) verifying sodium salt purity and pH specifications required for injectable formulations

• Declare as pharmaceutical active ingredient, not technical grade, to maintain drug classification and avoid higher chemical tariffs

• Provide evidence of intended medical use to prevent misclassification as industrial chemical intermediates